MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

BeiGene Ltd ADR

Closed

SectorHealthcare

255.76 2.58

Overview

Share price change

24h

Current

Min

251.89

Max

259.28

Key metrics

By Trading Economics

Income

-31M

-152M

Sales

126M

1.1B

Profit margin

-13.467

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+28.53% upside

Dividends

By Dow Jones

Next Earnings

7 May 2025

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

253.18

Previous close

255.76

BeiGene Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

29 Jan 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

27 Nov 2024, 15:22 UTC

Major Market Movers

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

21 Nov 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

22 Oct 2024, 18:39 UTC

Major Market Movers

Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment

27 Feb 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

12 Nov 2024, 11:01 UTC

Earnings

BeiGene 3Q Loss/Shr 9c >BGNE

12 Nov 2024, 11:01 UTC

Earnings

BeiGene 3Q Rev $1B >BGNE

7 Aug 2024, 10:05 UTC

Earnings

BeiGene 2Q Loss/Shr $1.15 >BGNE

7 Aug 2024, 10:04 UTC

Earnings

BeiGene 2Q Rev $929M >BGNE

8 May 2024, 10:02 UTC

Earnings

BeiGene 1Q Loss/Shr 19c >BGNE

8 May 2024, 10:01 UTC

Earnings

BeiGene 1Q Loss $251.2M >BGNE

8 May 2024, 10:01 UTC

Earnings

BeiGene 1Q Rev $752M >BGNE

Peer Comparison

Price change

BeiGene Ltd ADR Forecast

Price Target

By TipRanks

28.53% upside

12 Months Forecast

Average 320.21 USD  28.53%

High 359.47 USD

Low 259 USD

Based on 13 Wall Street analysts offering 12 month price targets forBeiGene Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeiGene Ltd ADR

BeiGene Ltd